Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone
- PMID: 16447240
- DOI: 10.1002/art.21620
Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone
Abstract
Objective: To compare the efficacy of doxycycline plus methotrexate (MTX) versus MTX alone in the treatment of early seropositive rheumatoid arthritis (RA), and to attempt to differentiate the antibacterial and antimetalloproteinase effects of doxycycline.
Methods: Sixty-six patients with seropositive RA of <1 year's duration who had not been previously treated with disease-modifying antirheumatic drugs were randomized to receive 100 mg of doxycycline twice daily with MTX (high-dose doxycycline group), 20 mg of doxycycline twice daily with MTX (low-dose doxycycline group), or placebo with MTX (placebo group), in a 2-year double-blind study. Treatment was started with an MTX dosage of 7.5 mg/week, which was titrated every 3 months until remission was reached (maximum dosage of 17.5 mg/week). The primary end point was an American College of Rheumatology 50% improvement (ACR50) response at 2 years.
Results: ACR50 responses were observed in 41.6% of patients in the high-dose doxycycline group, 38.9% of those in the low-dose doxycycline group, and 12.5% of patients in the placebo group. Results of chi-square analysis of the ACR50 response in the high-dose doxycycline group versus that in the placebo group were significantly different (P = 0.02). Trend analysis revealed that the ACR20 response and the ACR50 response were significantly different between groups (P = 0.04 and P = 0.03, respectively). MTX doses at 2 years were not different among groups. Four patients in the high-dose doxycycline group, 2 patients in the low-dose doxycycline group, and 2 patients in the placebo group were withdrawn because of toxic reactions.
Conclusion: In patients with early seropositive RA, initial therapy with MTX plus doxycycline was superior (based on an ACR50 response) to treatment with MTX alone. The therapeutic responses to low-dose and high-dose doxycycline were similar, suggesting that the antimetalloproteinase effects were more important than the antibacterial effects. Further studies to evaluate the mechanism of action of tetracyclines in RA are indicated.
Similar articles
-
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Clinical Trial.
-
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.Arthritis Rheum. 2002 Aug;46(8):2020-8. doi: 10.1002/art.10427. Arthritis Rheum. 2002. PMID: 12209503 Clinical Trial.
-
Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.Arthritis Rheum. 2004 Feb;50(2):364-71. doi: 10.1002/art.20167. Arthritis Rheum. 2004. PMID: 14872477 Clinical Trial.
-
Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.J Rheumatol. 2012 Jun;39(6):1198-206. doi: 10.3899/jrheum.111345. Epub 2012 Apr 15. J Rheumatol. 2012. PMID: 22505698 Review.
-
[Methotrexate for the treatment of rheumatoid arthritis in Japan--much more still remains to be resolved].Nihon Rinsho. 2002 Dec;60(12):2331-8. Nihon Rinsho. 2002. PMID: 12510358 Review. Japanese.
Cited by
-
Doxycycline reduces liver and kidney injuries in a rat hemorrhagic shock model.Intensive Care Med Exp. 2024 Jan 9;12(1):2. doi: 10.1186/s40635-023-00586-4. Intensive Care Med Exp. 2024. PMID: 38194181 Free PMC article.
-
Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Int J Endocrinol. 2015;2015:285698. doi: 10.1155/2015/285698. Epub 2015 Jun 29. Int J Endocrinol. 2015. PMID: 26221138 Free PMC article.
-
Doxycycline Attenuates Doxorubicin-Induced Cardiotoxicity by Improving Myocardial Energy Metabolism in Rats.J Cardiovasc Dev Dis. 2022 Aug 8;9(8):254. doi: 10.3390/jcdd9080254. J Cardiovasc Dev Dis. 2022. PMID: 36005418 Free PMC article.
-
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.Arthritis Rheum. 2013 Aug;65(8):1985-94. doi: 10.1002/art.38012. Arthritis Rheum. 2013. PMID: 23686414 Free PMC article. Clinical Trial.
-
Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.Int Dent J. 2016 Jun;66(3):127-35. doi: 10.1111/idj.12221. Epub 2016 Mar 23. Int Dent J. 2016. PMID: 27009489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical